BACKGROUND: Chronic inflammation is linked to poor lifestyle behaviors and a variety of chronic diseases that are prevalent among African Americans, especially in the southeastern U.S. PURPOSE: The goal of the study was to test the effect of a community-based diet, physical activity, and stress reduction intervention conducted in 2009-2012 on reducing serum C-reactive protein (CRP) in overweight and obese African-American adults. METHODS: An RCT intervention was designed jointly by members of African-American churches and academic researchers. In late 2012, regression (i.e., mixed) models were fit that included both intention-to-treat and post hoc analyses conducted to identify important predictors of intervention success. Outcomes were assessed at 3 months and 1 year. RESULTS: At baseline, the 159 individuals who were recruited in 13 churches and had evaluable outcome data were, on average, obese (BMI=33.1 [±7.1]) and had a mean CRP level of 3.7 (±3.9) mg/L. Reductions were observed in waist-to-hip ratio at 3 months (2%, p=0.03) and 1 year (5%, p<0.01). In female participants attending ≥60% of intervention classes, there was a significant decrease in CRP at 3 months of 0.8 mg/L (p=0.05), but no change after 1 year. No differences were noted in BMI or interleukin-6. CONCLUSIONS: In overweight/obese, but otherwise "healthy," African-American church members with very high baseline CRP levels, this intervention produced significant reductions in CRP at 3 and 12 months, and in waist-to-hip ratio, which is an important anthropometric predictor of overall risk of inflammation and downstream health effects. TRIAL REGISTRATION: This study is registered at www.clinicaltrials.gov NCT01760902.
RCT Entities:
BACKGROUND:Chronic inflammation is linked to poor lifestyle behaviors and a variety of chronic diseases that are prevalent among African Americans, especially in the southeastern U.S. PURPOSE: The goal of the study was to test the effect of a community-based diet, physical activity, and stress reduction intervention conducted in 2009-2012 on reducing serum C-reactive protein (CRP) in overweight and obese African-American adults. METHODS: An RCT intervention was designed jointly by members of African-American churches and academic researchers. In late 2012, regression (i.e., mixed) models were fit that included both intention-to-treat and post hoc analyses conducted to identify important predictors of intervention success. Outcomes were assessed at 3 months and 1 year. RESULTS: At baseline, the 159 individuals who were recruited in 13 churches and had evaluable outcome data were, on average, obese (BMI=33.1 [±7.1]) and had a mean CRP level of 3.7 (±3.9) mg/L. Reductions were observed in waist-to-hip ratio at 3 months (2%, p=0.03) and 1 year (5%, p<0.01). In female participants attending ≥60% of intervention classes, there was a significant decrease in CRP at 3 months of 0.8 mg/L (p=0.05), but no change after 1 year. No differences were noted in BMI or interleukin-6. CONCLUSIONS: In overweight/obese, but otherwise "healthy," African-American church members with very high baseline CRP levels, this intervention produced significant reductions in CRP at 3 and 12 months, and in waist-to-hip ratio, which is an important anthropometric predictor of overall risk of inflammation and downstream health effects. TRIAL REGISTRATION: This study is registered at www.clinicaltrials.gov NCT01760902.
Authors: Luigi Fontana; Dennis T Villareal; Edward P Weiss; Susan B Racette; Karen Steger-May; Samuel Klein; John O Holloszy Journal: Am J Physiol Endocrinol Metab Date: 2007-03-27 Impact factor: 4.310
Authors: Shun Kohsaka; Kelly A Volcik; Aaron R Folsom; Kenneth K Wu; Christie M Ballantyne; James T Willerson; Eric Boerwinkle Journal: Atherosclerosis Date: 2007-03-09 Impact factor: 5.162
Authors: James R Hébert; Kathryn L Braun; Joseph Keawe'aimoku Kaholokula; Cheryl A Armstead; James B Burch; Beti Thompson Journal: Prog Community Health Partnersh Date: 2015
Authors: Daria M McMahon; James B Burch; James R Hébert; James W Hardin; Jiajia Zhang; Michael D Wirth; Shawn D Youngstedt; Nitin Shivappa; Steven J Jacobsen; Bette Caan; Stephen K Van Den Eeden Journal: Ann Epidemiol Date: 2018-11-02 Impact factor: 3.797
Authors: María E Fernández; Cathy L Melvin; Jennifer Leeman; Kurt M Ribisl; Jennifer D Allen; Michelle C Kegler; Roshan Bastani; Marcia G Ory; Betsy C Risendal; Peggy A Hannon; Matthew W Kreuter; James R Hebert Journal: Cancer Epidemiol Biomarkers Prev Date: 2014-08-25 Impact factor: 4.254
Authors: Fred K Tabung; Susan E Steck; Jiajia Zhang; Yunsheng Ma; Angela D Liese; Ilir Agalliu; Melanie Hingle; Lifang Hou; Thomas G Hurley; Li Jiao; Lisa W Martin; Amy E Millen; Hannah L Park; Milagros C Rosal; James M Shikany; Nitin Shivappa; Judith K Ockene; James R Hebert Journal: Ann Epidemiol Date: 2015-03-19 Impact factor: 3.797
Authors: Swann Arp Adams; Michael D Wirth; Samira Khan; E Angela Murphy; Sue P Heiney; Lisa C Davis; Briana Davis; Ruby F Drayton; Thomas G Hurley; Steven N Blair; James R Hébert Journal: Prev Med Date: 2015-05-22 Impact factor: 4.018
Authors: M D Wirth; N Shivappa; L Davis; T G Hurley; A Ortaglia; R Drayton; S N Blair; J R Hébert Journal: J Nutr Health Aging Date: 2017 Impact factor: 4.075
Authors: Nitin Shivappa; James R Hébert; Valentina Rosato; Werner Garavello; Diego Serraino; Carlo La Vecchia Journal: Int J Cancer Date: 2017-05-09 Impact factor: 7.396
Authors: Malcolm Bevel; Oluwole A Babatunde; Sue P Heiney; Heather M Brandt; Michael D Wirth; Thomas G Hurley; Samira Khan; Hiluv Johnson; Cassandra M Wineglass; Tatiana Y Warren; E Angela Murphy; Erica Sercy; Amanda S Thomas; James R Hébert; Swann Arp Adams Journal: Ethn Dis Date: 2018-04-26 Impact factor: 1.847
Authors: Oluwole Adeyemi Babatunde; Swann Arp Adams; Samantha Truman; Erica Sercy; Angela E Murphy; Samira Khan; Thomas G Hurley; Michael D Wirth; Seul Ki Choi; Hiluv Johnson; James R Hebert Journal: Women Health Date: 2020-04-05